MYX News: There's No Escaping Mayne Pharma Group Limited's (ASX:MYX) Muted Revenues - 18th Apr 2023, 3:22pm

[annb0t]

Mayne Pharma Group Limited's (ASX:MYX) price-to-sales (or "P/S") ratio of 0.9x might make it look like a strong buy right now compared to the Pharmaceuticals industry in Australia, where around half of the companies have P/S ratios above 8.3x and even P/S above 28x are quite common. However, the P/S might be quite low for a reason and it requires further investigation to determine if it's justified.

Check out our latest analysis for Mayne Pharma Group ps-multiple-vs-industry

What Does Mayne P...

>>> Read more: There's No Escaping Mayne Pharma Group Limited's (ASX:MYX) Muted Revenues